
A publication of the American Society for Bone and Mineral Research
| Hello. Sign in to personalize your visit. New user? Register now. |
|
Abstract
Journal of Bone and Mineral Research, Journal of Bone and Mineral Research September 2005:20:1637-1646 (doi: 10.1359/JBMR.050521)
Molecular and Functional Expression of Voltage-Operated Calcium Channels During Osteogenic Differentiation of Human Mesenchymal Stem Cells Ihor Zahanich, 1 Eva M Graf, 1 Jürgen F Heubach, 1 Ute Hempel, 2 Sabine Boxberger, 3 Ursula Ravens1 1Institut für Pharmakologie und Toxikologie, Medizinische Fakultät Carl Gustav Carus der TU Dresden, Dresden, Germany; 2Institut für Physiologische Chemie, Medizinische Fakultät Carl Gustav Carus der TU Dresden, Dresden, Germany; 3Medizinische Klinik und Poliklinik I, Medizinische Fakultät Carl Gustav Carus der TU Dresden, Dresden, Germany. Address reprint requests to: Ursula Ravens, MD Institut für Pharmakologie und Toxikologie Medizinische Fakultät der TU Dresden Fetscherstrasse 74 D-01307 Dresden, Germany E-mail: ravens@rcs.urz.tu-dresden.de We used the patch-clamp technique and RT-PCR to study the molecular and functional expression of VOCCs in undifferentiated hMSCs and in cells undergoing osteogenic differentiation. L-type Ca2+ channel blocker nifedipine did not influence alkaline phosphatase activity, calcium, and phosphate accumulation of hMSCs during osteogenic differentiation. This study suggests that osteogenic differentiation of hMSCs does not require L-type Ca2+ channel function. Introduction: During osteogenic differentiation, mesenchymal stem cells from human bone marrow (hMSCs) must adopt the calcium handling of terminally differentiated osteoblasts. There is evidence that voltage-operated calcium channels (VOCCs), including L-type calcium channels, are involved in regulation of osteoblast function. We therefore studied whether VOCCs play a critical role during osteogenic differentiation of hMSCs. Materials and Methods: Osteogenic differentiation was induced in hMSCs cultured in maintenance medium (MM) by addition of ascorbate, β-glycerophosphate, and dexamethasone (ODM) and was assessed by measuring alkaline phosphatase activity, expression of osteopontin, osteoprotegerin, RANKL, and mineralization. Expression of Ca2+ channel α1 subunits was shown by semiquantitative or single cell RT-PCR. Voltage-activated calcium currents of hMSCs were measured with the whole cell voltage-clamp technique. Results: mRNA for the pore-forming α1C and α1G subunits of the L-type and T-type Ca2+ channels, respectively, was found in comparable amounts in cells cultured in MM or ODM. The limitation of L-type Ca2+ currents to a subpopulation of hMSCs was confirmed by single cell RT-PCR, where mRNA for the α1C subunits was detectable in only 50% of the cells cultured in MM. Dihydropyridine-sensitive L-type Ca2+ currents were found in 13% of cells cultured in MM and in 12% of the cells cultured in ODM. Under MM and ODM culture conditions, the cells positive for L-type Ca2+ currents were significantly larger than cells without Ca2+ currents as deduced from membrane capacitance; thus, current densities were comparable. Addition of the L-type Ca2+ channel blocker nifedipine to the culture media did not influence alkaline phosphatase activity and the extent of mineralization. Conclusion: These results suggest that, in the majority of hMSCs, Ca2+ entry through the plasma membrane is mediated by some channels other than VOCCs, and blockade of the L-type Ca2+ channels does not affect early osteogenic differentiation of hMSCs. |
|